|
Index of reports
> Cases resulting in a serious event (111)
> Cases with Disorientation (10)
Below is the selection of adverse event reports related to Lunesta (Eszopiclone) that includes cases resulting in a serious event where reactions include disorientation.
Adverse event in female receiving Lunesta (Eszopiclone)
Reported by a consumer/non-health professional from United States on 2007-10-11
Patient: female
Adverse reactions / side effects: Haematocrit Decreased, Nausea, Mental Status Changes, Disorientation, Haematemesis
Adverse event resulted in: hospitalization
Suspect drug(s):
Lunesta (Eszopiclone)
Other drugs received by patient: Trazodone HCL; Hormones and Related Agents; Metoclopramide; Methadone HCL; Metoprolol; Topramax; Glucophage; Nexium; Flexeril; Serevent; Iron; Zoloft
Adverse event in 61 year old female receiving Lunesta (Eszopiclone)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-07-13
Patient: 61 year old female, weighing 79.8 kg (175.6 pounds)
Adverse reactions / side effects: Disorientation, Neutropenia
Suspect drug(s):
Copegus
Dosage: 200 mg; qd; ora; 400 mg; qd; oral
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-03-14
End date: 2006-07-25
Copegus
Dosage: 200 mg; qd; ora; 400 mg; qd; oral
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-03-14
End date: 2006-07-25
Lunesta
Dosage: 2 mg; prn; oral
Administration route: Oral
Indication: Insomnia
Start date: 2006-06-06
End date: 2006-10-24
Pegasys
Dosage: 135 ug; qw; subcutaneous
Indication: Hepatitis C
Start date: 2006-03-14
End date: 2006-07-11
Other drugs received by patient: Epogen
Adverse event in 76 year old female receiving Lunesta (Eszopiclone)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-07-03
Patient: 76 year old female
Adverse reactions / side effects: Confusional State, General Physical Health Deterioration, Encephalitis, Catatonia, Disorientation, Meningitis Viral, Convulsion, Hypertensive Crisis, Speech Disorder, Depressed Level of Consciousness, Feeling Abnormal, Infection
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Aricept
Start date: 2007-06-01
Lunesta
Start date: 2007-06-07
Namenda
Start date: 2007-06-01
Other drugs received by patient: Ultram; Lortab (Hydrocodone); Naprosyn; Klonopin
Adverse event in 76 year old female receiving Lunesta (Eszopiclone)
Reported by a consumer/non-health professional from United States on 2007-06-27
Patient: 76 year old female
Adverse reactions / side effects: Confusional State, Dysphagia, Encephalitis, Catatonia, Meningitis Viral, Disorientation, Hypertensive Crisis, Convulsion, Speech Disorder, CSF Protein Increased, Depressed Level of Consciousness, Feeling Abnormal, Myocardial Infarction, Infection
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Aricept
Dosage: 1 in 1 d, oral
Administration route: Oral
Indication: Delusion
Start date: 2007-06-01
Lunesta
Dosage: oral
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 2007-06-06
Namenda
Dosage: oral
Administration route: Oral
Indication: Delusion
Start date: 2007-06-01
Other drugs received by patient: Ultram; Lortab; Naprosyn; Klonopin
Adverse event in 76 year old female receiving Lunesta (Eszopiclone)
Reported by a consumer/non-health professional from United States on 2007-06-27
Patient: 76 year old female
Adverse reactions / side effects: Confusional State, General Physical Health Deterioration, Encephalitis, Catatonia, Disorientation, Meningitis Viral, Convulsion, Hypertensive Crisis, Speech Disorder, CSF Protein Increased, Depressed Level of Consciousness, Feeling Abnormal, Infection
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Aricept
Dosage: 1 in 1 d, oral
Administration route: Oral
Indication: Delusion
Start date: 2007-06-01
Lunesta
Dosage: oral
Administration route: Oral
Start date: 2007-06-06
Namenda
Dosage: oral
Administration route: Oral
Indication: Delusion
Start date: 2007-06-01
Other drugs received by patient: Ultram; Lortab; Naprosyn (Naprosyn); Klonopin
Adverse event in 76 year old female receiving Lunesta (Eszopiclone)
Reported by a consumer/non-health professional from United States on 2007-06-18
Patient: 76 year old female
Adverse reactions / side effects: Confusional State, General Physical Health Deterioration, Catatonia, Disorientation, Convulsion, Hypertensive Crisis, Speech Disorder, Depressed Level of Consciousness, Feeling Abnormal, Myocardial Infarction, Infection
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Aricept
Dosage: oral
Administration route: Oral
Indication: Confusional State
Start date: 2007-06-01
Aricept
Dosage: oral
Administration route: Oral
Indication: Delusion
Start date: 2007-06-01
Lunesta
Dosage: oral
Administration route: Oral
Start date: 2007-06-06
Namenda
Dosage: oral
Administration route: Oral
Indication: Confusional State
Start date: 2007-06-01
Namenda
Dosage: oral
Administration route: Oral
Indication: Delusion
Start date: 2007-06-01
Other drugs received by patient: Ultram; Lortab; Naprosyn; Klonopin
Adverse event in 78 year old female receiving Lunesta (Eszopiclone)
Reported by a physician from United States on 2007-06-14
Patient: 78 year old female
Adverse reactions / side effects: Mental Status Changes, Disorientation
Adverse event resulted in: hospitalization
Suspect drug(s):
Lunesta (Eszopiclone)
Other drugs received by patient: Oxygen; Fluticasone Propionate; Albuterol; Vitamin D; Fosamax; Valsartan; Hydrochlorothiazide; Nasal Preparations; Tiotropium Bromide; Pantoprazole Sodium; Nasal Saline
Adverse event in 75 year old male receiving Lunesta (Eszopiclone)
Reported by a consumer/non-health professional from United States on 2007-04-26
Patient: 75 year old male, weighing 100.7 kg (221.5 pounds)
Adverse reactions / side effects: Body Temperature Increased, Head Injury, Osteoporosis, Disorientation, Fall, Treatment Noncompliance, Loss of Consciousness, Speech Disorder, Mania, Road Traffic Accident, Neck Pain, Depression, Blood Creatinine Increased, Diabetes Mellitus Inadequate Control, Flat Affect, Blood Urea Increased, Musculoskeletal Pain, Osteoarthritis, Irritability
Adverse event resulted in: hospitalization
Suspect drug(s):
Lunesta
Dosage: see image
Administration route: Oral
Indication: Insomnia
Start date: 2006-09-16
End date: 2006-09-16
Lunesta
Dosage: see image
Administration route: Oral
Indication: Insomnia
Start date: 2006-09-01
End date: 2006-09-21
Other drugs received by patient: Prozac; Trazodone HCL; Aspirin; Gemfibrozil; Zantac; Synthroid; Lantus; Potassium Acetate; Coreg; Furosemide; Lithium Carbonate; Simvastatin; Cozaar; Novolog
Adverse event in 59 year old male receiving Lunesta (Eszopiclone)
Reported by a consumer/non-health professional from United States on 2007-04-16
Patient: 59 year old male
Adverse reactions / side effects: Agitation, Abnormal Behaviour, Disorientation, Amnesia, Aggression, Incoherent, Skin Laceration, Gait Disturbance, Hypersomnia
Suspect drug(s):
Lunesta
Dosage: see image
Administration route: Oral
Start date: 2006-09-04
End date: 2006-09-01
Lunesta
Dosage: see image
Administration route: Oral
Start date: 2006-09-04
End date: 2006-09-04
Other drugs received by patient: Tramadol HCL
Adverse event in 61 year old female receiving Lunesta (Eszopiclone)
Reported by a physician from United States on 2007-04-10
Patient: 61 year old female, weighing 79.8 kg (175.6 pounds)
Adverse reactions / side effects: Disorientation
Suspect drug(s):
Lunesta
Administration route: Oral
Indication: Insomnia
Start date: 2006-06-06
End date: 2006-10-24
PEG-Interferon Alfa 2A (RO 25-8310)
Dosage: form reported as injectable solution.
Start date: 2006-03-14
End date: 2006-07-11
Ribavirin
Dosage: 200 mg am and 400 mg pm.
Administration route: Oral
Start date: 2006-03-14
End date: 2006-07-25
Other drugs received by patient: Procrit
|
